Kraig Labs expands domestic spider silk production in response to increased demand

ANN ARBOR, Mich., -July 26, 2016- Kraig Biocraft Laboratories, Inc. (OTCQB: KBLB) (“Company”), the leading developer of spider silk based fibers, today announced the signing of a lease, and taking of possession, for its new production facility in Indiana.  The Company has already begun interior construction and expects to have the facility ready for operations by August 10, 2016.  This facility is expected to increase the Company’s US production capacity by nearly twenty times.  This facility will be used to fulfill the Company’s recently awarded contract from the US Government and to potentially supply additional collaborative textile developers.

“This expanded domestic capacity should allow us to be more responsive to customers in both capacity and variety of spider silk materials,” said COO Jon Rice.  “This growth of our production capacity will allow us to expand our relationships with both industry and governmental collaborators.  We are looking forward to the inauguration of this new production facility within the next two weeks.”

To view the most recent edition of Kraig’s Spider Sense quarterly newsletter and/or to sign up for Company alerts, please go to www.kraiglabs.com/newsletter

About Kraig Biocraft Laboratories, Inc.
Kraig Biocraft Laboratories, Inc. (www.KraigLabs.com), a fully reporting biotechnology company is the leading developer of genetically engineered spider silk based fiber technologies. The Company has achieved a series of scientific breakthroughs in the area of spider silk technology with implications for the global textile industry.

Cautionary Statement Regarding Forward Looking Information
Statements in this press release about the Company’s future and expectations other than historical facts are “forward-looking statements.” These statements are made on the basis of management’s current views and assumptions. As a result, there can be no assurance that management’s expectations will necessarily come to pass. These forward-looking statements generally can be identified by phrases such as “believes,” “plans,” “expects,” “anticipates,” “foresees,” “estimated,” “hopes,” “if,” “develops,” “researching,” “research,” “pilot,” “potential,” “could” or other words or phrases of similar import. Forward looking statements include descriptions of the Company’s business strategy, outlook, objectives, plans, intentions and goals. All such forward-looking statements are subject to certain risks and uncertainties that could cause actual results to differ materially from those in forward-looking statements. This press release does not constitute an offer to sell or the solicitation of an offer to buy any security.

Ben Hansel, Hansel Capital, LLC

(720) 288-8495

ir@KraigLabs.com

ANN ARBOR, Mich., -July 18, 2016- Kraig Biocraft Laboratories, Inc. (OTCQB: KBLB) (“Company”), the leading developer of spider silk based fibers, announced today that the Company has signed an office lease in Ho Chi Minh City, Vietnam.  The opening of the Company’s first overseas office is in keeping with its plans to expand silk production.  The establishment of this office is seen by the Company as an essential step in its efforts to obtain final approval from Vietnamese authorities for its planned hybrid silkworm research and pilot production operations.

“The new office is intended to provide an essential gateway for our long term plans which include establishing pilot production and advanced research in traditional silk producing regions.  From these humble beginnings we hope to build lasting relationships and spur economic growth,” said Company COO Jon Rice.

To view the most recent edition of Kraig’s Spider Sense quarterly newsletter and/or to sign up for Company alerts, please go to www.KraigLabs.com/newsletter

About Kraig Biocraft Laboratories, Inc.
Kraig Biocraft Laboratories, Inc. (www.KraigLabs.com), a fully reporting biotechnology company is the leading developer of genetically engineered spider silk based fiber technologies. The Company has achieved a series of scientific breakthroughs in the area of spider silk technology with implications for the global textile industry.

Cautionary Statement Regarding Forward Looking Information
Statements in this press release about the Company’s future and expectations other than historical facts are “forward-looking statements.” These statements are made on the basis of management’s current views and assumptions. As a result, there can be no assurance that management’s expectations will necessarily come to pass. These forward-looking statements generally can be identified by phrases such as “believes,” “plans,” “expects,” “anticipates,” “foresees,” “estimated,” “hopes,” “if,” “develops,” “researching,” “research,” “pilot,” “potential,” “could” or other words or phrases of similar import. Forward looking statements include descriptions of the Company’s business strategy, outlook, objectives, plans, intentions and goals. All such forward-looking statements are subject to certain risks and uncertainties that could cause actual results to differ materially from those in forward-looking statements. This press release does not constitute an offer to sell or the solicitation of an offer to buy any security.

Ben Hansel, Hansel Capital, LLC

(720) 288-8495

ir@KraigLabs.com

ANN ARBOR, Mich., -July 12, 2016- Kraig Biocraft Laboratories, Inc. (OTCQB: KBLB) (“Company”), the leading developer of spider silk based fibers, today announced that it has received a contract valued at up to $1.0 million, if the option phase is awarded, for the development of high performance fibers for protective apparel applications. Under the fully funded base effort, valued at $99,962, the Company will deliver ballistic shoot packs constructed from its proprietary Dragon Silk™ material for performance testing.  These shoot packs will be tested and evaluated for critical Soldier protective applications including ballistic impact.  If awarded, the option phase will significantly expand this work with the US Army.

“Dragon Silk scores very highly in tensile strength and elasticity, which makes it one of the toughest fibers known to man and the ideal material for many applications,” stated Jon Rice, COO.  “Providing material for this ballistic shoot pack initiative is an important next step for Kraig and spider silk. This contract reinforces the many significant potential applications for recombinant spider silk. Today is a great day for spider silk.”

“We’re proud to be working with the Department of Defense to assess the exciting potential of spider silk for military applications,” stated Kim K Thompson, CEO and founder of Kraig Biocraft Laboratories. “We are honored that the U.S. Army has selected us for this program. This effort will provide Kraig Labs with the opportunity to validate our longstanding belief that spider silk technology has had an incredible potential for protective and lifesaving materials and expand our ability to design and engineer innovative materials solutions.”

The base effort on this contract is scheduled to last ten months and is the Company’s first US Department of Defense award.

To view the most recent edition of Kraig’s Spider Sense quarterly newsletter and/or to sign up for Company alerts, please go to www.KraigLabs.com/newsletter

About Kraig Biocraft Laboratories, Inc.

Kraig Biocraft Laboratories, Inc. (www.KraigLabs.com), a fully reporting biotechnology company is the leading developer of genetically engineered spider silk based fiber technologies.

The Company has achieved a series of scientific breakthroughs in the area of spider silk technology with implications for the global textile industry.

Cautionary Statement Regarding Forward Looking Information

Statements in this press release about the Company’s future and expectations other than historical facts are “forward-looking statements.” These statements are made on the basis of management’s current views and assumptions. As a result, there can be no assurance that management’s expectations will necessarily come to pass. These forward-looking statements generally can be identified by phrases such as “believes,” “plans,” “expects,” “anticipates,”

“foresees,” “estimated,” “hopes,” “if,” “develops,” “researching,” “research,” “pilot,” “potential,” “could” or other words or phrases of similar import. Forward looking statements include descriptions of the Company’s business strategy, outlook, objectives, plans, intentions and goals. All such forward-looking statements are subject to certain risks and uncertainties that could cause actual results to differ materially from those in forward-looking statements. This press release does not constitute an offer to sell or the solicitation of an offer to buy any security.

Ben Hansel, Hansel Capital, LLC

(720) 288-8495

ir@KraigLabs.com

Production Cost estimates Highlight the strategic positioning of Kraig’s Fibers

See the new report at: www.KraigLabs.com/comparison

ANN ARBOR, Mich., -June 7, 2016- Kraig Biocraft Laboratories, Inc. (OTCQB: KBLB) (“Company”), the leading developer of spider silk based fibers, today announced that the Company has published a new comparative analysis report featuring data related to the  global positioning of the company’s recombinant spider silk fibers.

“Given the various novel spider silk production techniques, management is extremely excited about how Kraig’s technology stacks up in this space.  Publishing this data is in line with our efforts to remain open and transparent as possible.  Our goal has always been to do more than just develop innovative wonder fibers. The results of this report reinforce our beliefs that we can deliver an outstanding value proposition for our customers, as well,” stated COO Jon Rice.

To view the most recent edition of Kraig’s Spider Sense quarterly newsletter and/or to sign up for Company alerts, please go to www.KraigLabs.com/newsletter

About Kraig Biocraft Laboratories, Inc.
Kraig Biocraft Laboratories, Inc. (www.KraigLabs.com), a fully reporting biotechnology company is the leading developer of genetically engineered spider silk based fiber technologies. The Company has achieved a series of scientific breakthroughs in the area of spider silk technology with implications for the global textile industry.

Cautionary Statement Regarding Forward Looking Information
Statements in this press release about the Company’s future and expectations other than historical facts are “forward-looking statements.” These statements are made on the basis of management’s current views and assumptions. As a result, there can be no assurance that management’s expectations will necessarily come to pass. These forward-looking statements generally can be identified by phrases such as “believes,” “plans,” “expects,” “anticipates,” “foresees,” “estimated,” “hopes,” “if,” “develops,” “researching,” “research,” “pilot,” “potential,” “could” or other words or phrases of similar import. Forward looking statements include descriptions of the Company’s business strategy, outlook, objectives, plans, intentions and goals. All such forward-looking statements are subject to certain risks and uncertainties that could cause actual results to differ materially from those in forward-looking statements. This press release does not constitute an offer to sell or the solicitation of an offer to buy any security.

Ben Hansel, Hansel Capital, LLC

(720) 288-8495

ir@KraigLabs.com

ANN ARBOR, Mich., -May 24, 2016- Kraig Biocraft Laboratories, Inc. (OTCQB: KBLB) (“Kraig”), the leading developer of spider silk based fibers, today announced that it has completed the biosafety and project risk assessment for its planned operations and subsidiary in Vietnam.  These documents were prepared in response to a request from the Vietnamese government to help them better understand the new technology the Company plans to introduce.  The Company is now waiting for document processing by the U.S. State Department and expects to send these documents to officials in Vietnam shortly.

“Completing this detailed review for Vietnam provided us with the opportunity to dive deep into our scale up plans,” said COO Jon Rice.  “By completing this process we have better prepared ourselves to begin operations in Vietnam or in any of the parallel production locations we are currently exploring.”

For the most recent edition of Kraig’s Spider Sense quarterly newsletter and to keep up with the latest news, please go to www.KraigLabs.com/newsletter

About Kraig Biocraft Laboratories, Inc.
Kraig Biocraft Laboratories, Inc. (www.KraigLabs.com), a fully reporting biotechnology company is the leading developer of genetically engineered spider silk based fiber technologies. The Company has achieved a series of scientific breakthroughs in the area of spider silk technology with implications for the global textile industry.

Cautionary Statement Regarding Forward Looking Information
Statements in this press release about the Company’s future and expectations other than historical facts are “forward-looking statements.” These statements are made on the basis of management’s current views and assumptions. As a result, there can be no assurance that management’s expectations will necessarily come to pass. These forward-looking statements generally can be identified by phrases such as “believes,” “plans,” “expects,” “anticipates,” “foresees,” “estimated,” “hopes,” “if,” “develops,” “researching,” “research,” “pilot,” “potential,” “could” or other words or phrases of similar import. Forward looking statements include descriptions of the Company’s business strategy, outlook, objectives, plans, intentions and goals. All such forward-looking statements are subject to certain risks and uncertainties that could cause actual results to differ materially from those in forward-looking statements. This press release does not constitute an offer to sell or the solicitation of an offer to buy any security.

Ben Hansel, Hansel Capital, LLC

(720) 288-8495

ir@KraigLabs.com

ANN ARBOR, Mich., – May 16, 2016 – Kraig Biocraft Laboratories, Inc. (OTCQB: KBLB) (“Company”), the leading developer of spider silk based fibers, today announced that the Company is planning on establishing more than one additional production location, including domestic options, that would operate in parallel to its announced plans for operations in Vietnam.

The additional production sites will allow Kraig Labs to more rapidly fulfill outstanding material requests, from our collaboration partners and prospective clients, for recombinant spider silk fibers.

“Although securing a healthy supply of suitable mulberry leaves, to establish our domestic production, is a challenge, I believe that this initiative will yield many benefits, including enhancement of our R&D efforts.  Additionally, some of our end users may require that certain fibers are produced domestically, so this move places us ahead of that curve,” said COO Jon Rice.

For further information from the Spider Sense quarterly newsletter and/or to sign up for Company alerts, please go to www.kraiglabs.com/newsletter/ 

About Kraig Biocraft Laboratories, Inc.
Kraig Biocraft Laboratories, Inc. (www.KraigLabs.com), a fully reporting biotechnology company is the leading developer of genetically engineered spider silk based fiber technologies. The Company has achieved a series of scientific breakthroughs in the area of spider silk technology with implications for the global textile industry.

Cautionary Statement Regarding Forward Looking Information
Statements in this press release about the Company’s future and expectations other than historical facts are “forward-looking statements.” These statements are made on the basis of management’s current views and assumptions. As a result, there can be no assurance that management’s expectations will necessarily come to pass. These forward-looking statements generally can be identified by phrases such as “believes,” “plans,” “expects,” “anticipates,” “foresees,” “estimated,” “hopes,” “if,” “develops,” “researching,” “research,” “pilot,” “potential,” “could” or other words or phrases of similar import. Forward looking statements include descriptions of the Company’s business strategy, outlook, objectives, plans, intentions and goals. All such forward-looking statements are subject to certain risks and uncertainties that could cause actual results to differ materially from those in forward-looking statements. This press release does not constitute an offer to sell or the solicitation of an offer to buy any security.

Ben Hansel, Hansel Capital, LLC

(720) 288-8495

ir@KraigLabs.com

Kraig Labs continues to expand its inventory of revolutionary transgenics

ANN ARBOR, Mich., – May 10, 2016 – Kraig Biocraft Laboratories, Inc. (OTCQB: KBLB) (“Company”), the leading developer of spider silk based fibers, today announced the creation of four new lines of transgenic silkworms.  These new transgenics are based on a new set of the Company’s most complex protein designs to date.  These new designs are targeted for applications in performance apparel, medical, and ballistic protection, where their intended strength improvements should provide even higher levels of durability. The Company believes that these new transgenics have the potential to produce silk fibers with an unprecedented combination of physical properties with the potential to rival its existing Dragon Silk^TM line.  Over the next several months the Company will start testing each of these newly created transgenics to measure their performance and use for targeted application.

“These are the most complex genetic constructions that we have ever created in the Company’s history,” said COO Jon Rice.  “In some cases, these designs took more than 12 months to perfect and we are just now able to confirm that this work has resulted in successful transgenics. This work represents a significant breakthrough in our efforts to bring transformative technical fibers to market and is a clear demonstration of our capability for continuous innovation.”

The Company expects to announce more details on the performance of these new materials over the coming months as performance testing is completed and each of these new transgenic silkworm lines obtain homozygosity.

About Kraig Biocraft Laboratories, Inc.

Kraig Biocraft Laboratories, Inc. (www.KraigLabs.com), a fully reporting biotechnology company is the leading developer of genetically engineered spider silk based fiber technologies. The Company has achieved a series of scientific breakthroughs in the area of spider silk technology with implications for the global textile industry.

Cautionary Statement Regarding Forward Looking Information

Statements in this press release about the Company’s future and expectations other than historical facts are “forward-looking statements.” These statements are made on the basis of management’s current views and assumptions. As a result, there can be no assurance that management’s expectations will necessarily come to pass. These forward-looking statements generally can be identified by phrases such as “believes,” “plans,” “expects,” “anticipates,” “foresees,” “estimated,” “hopes,” “if,” “develops,” “researching,” “research,” “pilot,” “potential,” “could” or other words or phrases of similar import. Forward looking statements include descriptions of the Company’s business strategy, outlook, objectives, plans, intentions and goals. All such forward-looking statements are subject to certain risks and uncertainties that could cause actual results to differ materially from those in forward-looking statements.

This press release does not constitute an offer to sell or the solicitation of an offer to buy any security.

Ben Hansel, Hansel Capital, LLC.

(720) 288-8495

ir@KraigLabs.com

Kraig Labs now preparing for launch of new Vietnamese subsidiary

ANN ARBOR, Mich., – February 29, 2016 – Kraig Biocraft Laboratories, Inc. (OTCQB: KBLB) (“Company”), the leading developer of spider silk based fibers, today announced the signing of a cooperative agreement with a governmental entity in Vietnam to develop and produce the Company’s advanced silk technologies.  Under the terms of the agreement Kraig Labs has agreed to form a subsidiary company in Vietnam and to open an advanced hybrid silk research and pilot production operation.

Kraig Labs has created an efficient method of producing high strength silks using its innovative genetic engineering technologies.  Demonstrating superior strength and elasticity, in some cases higher strength and elasticity than native spider silks, Kraig Labs’ Dragon Silk^TM has the potential to reshape the textile industry.  The research and production agreement announced today lays the groundwork for the production and further development of these advanced hybrid textiles.

“This agreement represents a major advancement for Kraig Labs and is the successful culmination of two years of negotiations and many more years of scientific research and development,” said CEO and Founder Kim Thompson. “It is a key milestone in the advancement of our longstanding business plan to bring these advanced materials to the multi-billion dollar marketplace for advanced technical textiles.  It brings us a huge step closer to meeting the demand for our spider silk technologies. This agreement is important because of the tremendous existing silk and textile production infrastructure.  At the same time bringing a new technology and capability to Vietnam.  This agreement was the result of considerable effort by all parties involved and we are pleased to announce today the success of those efforts.  I would like to personally thank our negotiation partners for their dedication in completing this first of its kind international agreement.”

The Company is currently in the process of obtaining the necessary approvals for the subsidiary and its operational plan.  Over the next several months the Company plans to finalize the formation of the subsidiary, lease a research and production facility in Vietnam, hire and train local staff, obtain permits, and begin cross breeding its silkworms with local commercial silkworm lines.

About Kraig Biocraft Laboratories, Inc.

Kraig Biocraft Laboratories, Inc. (www.KraigLabs.com), a fully reporting biotechnology company is the leading developer of genetically engineered spider silk based fiber technologies. The Company has achieved a series of scientific breakthroughs in the area of spider silk technology with implications for the global textile industry.

Cautionary Statement Regarding Forward Looking Information

Statements in this press release about the Company’s future and expectations other than historical facts are “forward-looking statements.” These statements are made on the basis of management’s current views and assumptions. As a result, there can be no assurance that management’s expectations will necessarily come to pass. These forward-looking statements generally can be identified by phrases such as “believes,” “plans,” “expects,” “anticipates,” “foresees,” “estimated,” “hopes,” “if,” “develops,” “researching,” “research,” “pilot,” “potential,” “could” or other words or phrases of similar import. Forward looking statements include descriptions of the Company’s business strategy, outlook, objectives, plans, intentions and goals. All such forward-looking statements are subject to certain risks and uncertainties that could cause actual results to differ materially from those in forward-looking statements.

This press release does not constitute an offer to sell or the solicitation of an offer to buy any security.

Ben Hansel, Hansel Capital, LLC.

(720) 288-8495

ir@KraigLabs.com